首页|腹膜透析患者幽门螺杆菌感染影响因素分析

腹膜透析患者幽门螺杆菌感染影响因素分析

扫码查看
目的 探讨腹膜透析(PD)患者幽门螺杆菌(Hp)感染的影响因素.方法 92例PD患者依据14C尿素呼气试验检测结果分为Hp感染组(40例)与Hp未感染组(52例).比较两组患者一般资料、营养指标、炎症相关指标和透析充分性相关指标等.采用多因素logistic回归分析PD患者Hp感染的影响因素.结果 与Hp未感染组相比,Hp感染组患者年龄大,透析龄长,超敏CRP、TNF-α、IFN-γ、IL-6水平高,Hb、白蛋白、24-h尿量、24-h超滤量、总尿素清除指数(Kt/V)、残肾Kt/V、总肌酐清除率(Ccr)和残肾Ccr低(P<0.05).多因素logistic回归分析结果显示,年龄大、透析龄长是PD患者Hp感染的独立危险因素,而残肾Kt/V和残肾Ccr升高是其独立保护因素(P<0.05).结论 PD患者是Hp感染的高危人群,且Hp感染与炎症反应和透析充分性密切相关,抗Hp治疗可能对改善PD患者预后有积极作用.
An analysis of influencing factors of Helicobacter pylori infection in peritoneal dialysis patients
Objective To explore the influencing factors of Helicobacter pylori(Hp)infection in the patients undergoing peritoneal dialysis(PD).Methods Ninety-two PD patients were divided into two groups of A(with Hp infection,40 cases)and B(without Hp infection,52 cases)based on the results of 14C urea breath test.The general information,nutritional indicators,inflammation-related indicators and dialysis adequacy-related indicators of two groups were compared.Multivariate logistic regression analysis was used to investigate the influencing factors of Hp infection in PD patients.Results Compared with group B,the patients in group A were older and had longer dialysis age,higher levels of hsCRP,TNF-α,INF-γ,IL-6 and lower levels of Hb,Alb,24-h urine volume,24-h ultrafiltration volume,total Kt/V,Kt/V of residual kidney,total Ccr and residual kidney Ccr(P<0.05).Multivariate logistic regression analysis showed that older age and longer dialysis age were the independent risk factors for Hp infection in PD patients,while increased Kt/V and Ccr of residual kidney were the independent protective factors for Hp infection of PD patients(P<0.05).Conclusion PD patients are at high risk of Hp infection,and Hp infection is closely related to inflammatory response and dialysis adequacy.Anti-Hp treatment may have a positive effect on improving the prognosis of PD patients.

Helicobacter pyloriPeritoneal dialysis

沈飞凤、黄益麒、沈伟钢

展开 >

312000 浙江,绍兴第二医院血液净化中心

312000 浙江,绍兴第二医院肾内科

幽门螺杆菌 腹膜透析

浙江省医药卫生科技计划项目

2023XY059

2024

江苏医药
江苏省人民医院(南京医科大学第一附属医院)

江苏医药

影响因子:0.707
ISSN:0253-3685
年,卷(期):2024.50(1)
  • 11